Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1
AMSGP
AMSGP was delisted on the 1st of December, 2016.
0 hedge funds and large institutions have $0 invested in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.
100% less funds holding
Funds holding: 21 → 0 (-21)
100% less capital invested
Capital invested by funds: $185M → $0 (-$185M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 21
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$54.1M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$28.6M |
| 3 |
Calamos Advisors
Naperville,
Illinois
|
-$23.3M |
| 4 |
D.E. Shaw & Co
New York
|
-$15.2M |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$11.3M |
AMSGP Hedge Fund Activity: Q4 2016 in Review
0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) for Q4 2016, worth a combined $0 — down 100% from $185M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of AMSGP and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Fidelity Investments, exiting entirely with an estimated $54.1M sold.
- 0 institutional investors held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) as of Q4 2016, down from 21 in Q3 2016.
- Funds reported $0 of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 stock for Q4 2016, down 100% quarter-over-quarter.
- 0 funds opened new Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 positions in Q4 2016 and 21 closed out, a net change of -21 holders.
- The largest Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 seller in Q4 2016 was Fidelity Investments, an estimated $54.1M sold.
Based on aggregated 13F filings for Q4 2016.